Projekt

VeRVe: Observational study of the use of venetoclax in patients with chronic lymphocytic leukemia (CLL) under real-life setting in Austria,Germany and Switzerland (Venetoclax Real Value)

Automatisch geschlossen · 2020 bis 2022

Baumann Michael